全球癌症營養市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計癌症營養市場將從 2025 年的 30.4 億美元成長到 2034 年的 53.5 億美元，2026 年至 2034 年的複合年成長率為 6.46%。

受癌症發病率上升和人們對輔助治療意識增強的推動，全球癌症營養市場正穩步成長。癌症營養產品旨在滿足癌症患者的特定營養需求，有助於維持患者的身體功能並改善治療效果。對個人化醫療的日益重視以及對提高患者生活品質的追求，正在推動對特殊營養補充劑和特殊醫學用途配方食品的需求。

關鍵成長要素包括臨床營養研究的進步和標靶治療的日益普及。醫療保健提供者擴大推薦營養干預措施來控制治療相關的副作用，例如體重減輕和疲勞。醫院基礎設施和腫瘤護理中心的擴建也進一步推動了產品需求。此外，癌症護理宣傳活動的加強也促進了市場成長。

展望未來，個人化營養處方和產品偏好提升的創新可望進一步推動市場發展。新興經濟體不斷擴建的癌症治療設施將創造新的成長機會。各公司正致力於研發主導解決方案，並與醫療服務提供者建立策略夥伴關係。隨著綜合癌症治療的重要性日益凸顯，全球癌症營養市場預計將穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球癌症營養市場：依癌症類型分類

• 市場分析、洞察與預測
• 頭頸癌
• 結腸癌
• 血癌
• 攝護腺癌
• 乳癌
• 胃腸道癌症
• 肺癌
• 胰臟癌
• 其他

第5章：全球癌症營養市場：依營養類型分類

• 市場分析、洞察與預測
• 經腸營養
• 腸外營養

第6章 全球癌症營養品市場：依配方分類

• 市場分析、洞察與預測
• 標準公式
• 元素式
• 特殊配方

第7章 全球癌症營養市場：依通路分類

• 市場分析、洞察與預測
• 住院患者的營養管理
• 門診營養管理

第8章 全球癌症營養市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Danone SA
  • Pfizer Inc
  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Grifols SA
  • Baxter International Inc
  • Nestle SA
  • Abbott Laboratories
  • AbbVie Inc
  • Sichuan Kelun Pharmaceutical Co. Ltd

The Oncology Nutrition Market size is expected to reach USD 5.35 Billion in 2034 from USD 3.04 Billion (2025) growing at a CAGR of 6.46% during 2026-2034.

The Global Oncology Nutrition Market is growing steadily due to increasing cancer prevalence and rising awareness of supportive care therapies. Oncology nutrition products are designed to meet the specific dietary needs of cancer patients, helping maintain strength and improve treatment outcomes. Growing emphasis on personalized healthcare and improved patient quality of life is driving demand for specialized nutritional supplements and medical foods.

Key growth drivers include advancements in clinical nutrition research and rising adoption of targeted therapies. Healthcare providers are increasingly recommending nutritional interventions to manage treatment-related side effects such as weight loss and fatigue. Expanding hospital infrastructure and oncology care centers are further supporting product demand. Additionally, growing awareness campaigns about cancer care are strengthening market growth.

Looking ahead, the market is expected to benefit from innovations in personalized nutrition formulations and improved product palatability. Emerging economies with expanding cancer treatment facilities will create new growth opportunities. Companies are focusing on research-driven solutions and strategic collaborations with healthcare providers. As comprehensive cancer care gains importance, the Global Oncology Nutrition Market is projected to expand steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Cancer Type

• Head and Neck Cancer
• Colorectal Cancer
• Hematology Cancer
• Prostate Cancer
• Breast Cancer
• Gastrointestinal Cancer
• Lung Cancer
• Pancreatic Cancer
• Others

By Nutrition

• Enteral Nutrition
• Parenteral Nutrition

By Formula

• Standard Formula
• Elemental Formula
• Specialized Formula

By Distribution Channel

• Inpatient Nutrition
• Outpatient Nutrition

COMPANIES PROFILED

• Danone SA, Pfizer Inc, B Braun Melsungen AG, Fresenius Kabi AG, Grifols SA, Baxter International Inc, Nestle SA, Abbott Laboratories, AbbVie Inc, Sichuan Kelun Pharmaceutical Co Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ONCOLOGY NUTRITION MARKET: BY CANCER TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Cancer Type
• 4.2. Head and Neck Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Colorectal Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Hematology Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Prostate Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Gastrointestinal Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Lung Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Pancreatic Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ONCOLOGY NUTRITION MARKET: BY NUTRITION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Nutrition
• 5.2. Enteral Nutrition Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Parenteral Nutrition Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ONCOLOGY NUTRITION MARKET: BY FORMULA 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Formula
• 6.2. Standard Formula Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Elemental Formula Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Specialized Formula Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ONCOLOGY NUTRITION MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Distribution Channel
• 7.2. Inpatient Nutrition Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Outpatient Nutrition Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ONCOLOGY NUTRITION MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Cancer Type
  • 8.2.2 By Nutrition
  • 8.2.3 By Formula
  • 8.2.4 By Distribution Channel
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Cancer Type
  • 8.3.2 By Nutrition
  • 8.3.3 By Formula
  • 8.3.4 By Distribution Channel
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Cancer Type
  • 8.4.2 By Nutrition
  • 8.4.3 By Formula
  • 8.4.4 By Distribution Channel
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Cancer Type
  • 8.5.2 By Nutrition
  • 8.5.3 By Formula
  • 8.5.4 By Distribution Channel
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Cancer Type
  • 8.6.2 By Nutrition
  • 8.6.3 By Formula
  • 8.6.4 By Distribution Channel
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL ONCOLOGY NUTRITION INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Danone S.A
  • 10.2.2 Pfizer Inc
  • 10.2.3 B. Braun Melsungen AG
  • 10.2.4 Fresenius Kabi AG
  • 10.2.5 Grifols S.A
  • 10.2.6 Baxter International Inc
  • 10.2.7 Nestle S.A
  • 10.2.8 Abbott Laboratories
  • 10.2.9 AbbVie Inc
  • 10.2.10 Sichuan Kelun Pharmaceutical Co. Ltd